PARIS — Results from the first study of the Omni surgical system in glaucoma patients suggest a favorable safety profile and long-term reductions in IOP and IOP-lowering medications, Sight Sciences presented at the European Society of Cataract and Refractive Surgeons meeting.
The pilot study, which included 24 eyes of 19 mild to moderate primary open-angle glaucoma patients who were treated with the Omni system, found a mean IOP reduction of 40% at 18 months and a mean medication reduction of 41%.
“With its unique capability to perform two sequential outflow (Read more...)
Uncategorized